High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 10, 2002, Pages 754-763

  Kikuchi, Kazuo ^a   Ohishi, Takayoshi ^a   Masuike, Taketoshi ^a   Ohmori, Kenji ^a   Sakai, Kenichi ^a  

^a Kyowa Hakko Koggo Co   (Japan)

Author keywords

Antiallergic drug; CAS 60607 34 3 Oxatomide; HPLC determination; Pharmacokinetics; Rat

Indexed keywords

ANTIALLERGIC AGENT; DRUG METABOLITE; ETHER; OXATOMIDE; SULFURIC ACID;

ALLERGIC RHINITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; ECZEMA; FEEDING BEHAVIOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PLASMA; PRURITUS; RAT;

EID: 0036406534     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299962     Document Type: Article

References (11)

1. Marone, G., Granata, E, Spadaro, G. et al., Antiinflammatory effects of oxatomide. J. Investig. Allergol. Clin. Immunol. 9, 207 (1999)
2. Richards, D. M., Brogden, R. N., Heel, R. C. et al., Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 27, 210 (1984)
3. Tasaka, K., Akagi, M., Mio, M. et al., Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells. Int. Arch. Allergy Appl. Immunol. 83, 348 (1987)
4. Manabe, H., Ohmori, K., Tomioka, H. et al., Oxatomide inhibits the release of chemical mediators from human lung tissues and from granulocytes. Int. Arch. Allergy Appl. Immunol. 87, 91 (1988)
5. Ohmori, K., Ishii, H., Hirayama, T. et al., Pharmacological studies on oxatomide (KW-4354): (1) Effect on passive cutaneous anaphylaxis (PCA) in rats and guinea pigs. Nippon Yakurigaku Zasshi - Folia Pharmacol. Japan, 80, 251 (1982)
6. 2) from rat mast cells and guinea-pig lung. Agents Actions 21, 32 (1987)
7. Ohmori, K., Ishii, H., Kubota, T. et al., Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats. Arch. Int. Pharmacodyn. Ther. 275, 139 (1985)
8. Ohmori, K., Ishii, H., Nito, M. et al., Pharmacological studies on oxatomide (KW-4354): (7) Antagonistic effects on chemical mediators, Nippon Yakurigaku Zasshi - Folia Pharmacol. Japan. 81, 399 (1983)
9. Nijkamp, F. P., Folkerts, G., Beetens, J. R. et al., Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: Mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 340, 111 (1989)
10. Meuldermans, W., Hendrickx, J., Knaeps, F. et al., Plasma levels, biotransformation and excretion of oxatomide (R35443) in rats, dog and man. Xenobiotica 14, 445 (1984)
11. Ohya, N., Miyauchi, M., Maruyama, S. et al., Clinicopharmacological evaluation of oxatomide in allergodermia - Effect of single administration per day of oxatomide on atopic dermatitis and urticaria. Nisinihonhihuka 55, 123 (1993)